A case for external reference pricing to regulate drug costs in low- and middle-income countries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A case for external reference pricing to regulate drug costs in low- and middle-income countries

Published:2021-10-02 Issue:10 Volume:27 Page:1-4
ISSN:1358-0574
Container-title:British Journal of Healthcare Management
language:en
Short-container-title:British Journal of Healthcare Management

Author:

Ashraf Amirul¹,Ong Siew Chin¹

Affiliation:

1. School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

Abstract

Amirul Ashraf and Siew Chin Ong discuss external reference pricing as a possible method of navigating the complex issue of drug pricing in Malaysia.

Publisher

Mark Allen Group

Subject

Health Policy,Leadership and Management

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/bjhc.2021.0050

Reference9 articles.

1. The new regulatory tools of the 2016 Health Law to fight drug shortages in France

2. External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage

3. Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally?

4. Addressing Generic-Drug Market Failures — The Case for Establishing a Nonprofit Manufacturer

5. Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP